Retatrutide vs Semaglutide Pricing Comparison

A retatrutide vs semaglutide pricing comparison usually starts with the sticker price on a listing page, but that number alone is not a useful comparison point. Vial size, peptide content, and molecular weight all shift the real cost per milligram, and the two compounds are priced differently enough that a straight vial-to-vial comparison can be misleading. This article walks through how listings for each compound are structured, how to normalize them to a common unit, and what tends to explain the gap between the two.

Why the Two Compounds Are Priced Differently

Retatrutide is a larger, triple receptor-targeting peptide, while semaglutide is a smaller, single receptor-targeting peptide. Peptide synthesis cost scales with the complexity and length of the amino acid chain, and retatrutide’s structure is more involved to manufacture at research-grade purity. That difference shows up upstream, before a single listing is ever priced, and it is one of the more consistent reasons retatrutide vial prices tend to sit above semaglutide vial prices at comparable purity tiers.

Vial sizing conventions also differ across listings. Semaglutide is commonly sold in smaller total-mg vials, since typical protocols referenced in literature use smaller unit doses, whereas retatrutide listings more often appear in higher total-mg vials. Comparing a 5 mg semaglutide vial to a 10 mg retatrutide vial on price alone tells you almost nothing about which is more expensive per unit of peptide.

Normalizing to Price per Milligram

The only way to compare listings meaningfully is to convert every price to a price-per-mg figure. The formula is simple:

price per mg = vial price / vial mg content

If a retatrutide listing shows a 10 mg vial at a given price, and a semaglutide listing shows a 5 mg vial at a lower price, dividing each by its mg content produces two numbers that can be placed side by side. This step matters because listing pages rarely display price-per-mg directly, and the vial price alone anchors the reader on the wrong comparison.

A Worked Example

Suppose a retatrutide listing shows a 10 mg vial, and a semaglutide listing shows a 5 mg vial. To compare them fairly, divide each vial price by its mg content.

Compound	Vial size	Vial price (example)	Price per mg
Retatrutide	10 mg	$220	$220 / 10 = $22.00 per mg
Semaglutide	5 mg	$95	$95 / 5 = $19.00 per mg

In this example, retatrutide’s per-mg figure ($22.00) is higher than semaglutide’s ($19.00), even though the retatrutide vial contains twice the total peptide of the semaglutide vial. Recomputing: $220 divided by 10 is $22.00, and $95 divided by 5 is $19.00 — both check out. This is the calculation to run on any two listings before assuming one compound is “cheaper” than another; the raw vial price by itself would have suggested retatrutide costs more than twice as much, when the actual per-mg gap is much narrower.

Reconstitution and Its Effect on the Numbers

Once a vial is reconstituted with bacteriostatic water, the concentration — not the vial price — determines how the peptide is measured out on a syringe. Concentration is calculated as:

concentration (mg/mL) = vial mg / mL of bacteriostatic water added

For example, a 10 mg retatrutide vial reconstituted with 2 mL of bacteriostatic water yields a concentration of 10 / 2 = 5 mg/mL. On a U-100 insulin syringe, where 1 mL equals 100 units, that concentration means each 10-unit mark corresponds to 0.5 mg, since 10 units is 0.1 mL and 0.1 mL times 5 mg/mL is 0.5 mg. This reconstitution step does not change what a vial costs, but it does change how far a given vial’s mg content is understood to go on a per-draw basis, which is a separate variable from price entirely. Listings that specify a suggested reconstitution volume are giving a concentration reference point, not a dosing instruction.

What Else Moves the Price Gap

Beyond raw synthesis cost, a few other factors show up consistently across listings for both compounds:

• Purity tier: Listings advertising higher HPLC purity percentages generally carry a price premium, and this premium tends to be more pronounced for retatrutide given its more complex synthesis.
• Batch and lab testing documentation: Listings that include third-party certificates of analysis often price slightly above listings that do not, for either compound.
• Vendor catalogue breadth: Some vendors carry a wide range of research peptides rather than specializing in one or two compounds, and sourcing retatrutide from a broader catalogue, such as the HEEZ Research listing, can make it easier to compare purity documentation and vial sizing conventions across compounds side by side rather than cross-referencing several single-compound vendors.
• Regional and currency factors: Listings priced in different currencies or shipped from different regions introduce additional variance that has nothing to do with the peptide itself.

None of these factors are unique to one compound, but because retatrutide’s baseline per-mg cost tends to run higher, the same percentage premium translates into a larger absolute dollar difference.

Reading Listings Side by Side

When comparing a retatrutide vs semaglutide pricing comparison across multiple vendors, the more reliable approach is to build a small table: vial size, vial price, calculated price per mg, and purity tier, for each listing under consideration. Vial price alone answers the wrong question. Price per mg, checked against purity documentation, answers the question a reader is actually asking when they compare these two compounds. For readers working across a broader set of compounds, the same three-column approach — size, price, resulting per-mg figure — applies whether the comparison is retatrutide against semaglutide or any other pair of listings in a given catalogue, and it is worth cross-checking reconstitution math independently at a source such as peptcalc.com before relying on any single listing’s stated concentration.

Summary

Retatrutide and semaglutide listings are not directly comparable at the vial-price level because vial sizes and synthesis costs differ between the two compounds. Converting each listing to a price-per-mg figure, and separately tracking reconstituted concentration for any dosing math, gives a clearer picture of where the real cost difference lies. Purity tier, testing documentation, and vendor catalogue breadth all shift the numbers further, which is why a single side-by-side table tends to be more informative than comparing sticker prices alone. For related pricing references across the network, see peer retatrutide listing catalogs.